A single inhalation dose study to assess efficacy, pharmacokinetics (PK), safety and tolerability of AZD8871 in patients with long-term lung diseases.

Trial Identifier: D6640C00006
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT03645434
Start Date: October 2018
Primary Completion Date: August 2019
Study Completion Date: August 2019
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations